Trials / Completed
CompletedNCT01901289
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Zilver® PTX® V Clinical Study is a post-market clinical trial required by the US FDA to provide continued evaluation of the safety and effectiveness of the Zilver PTX Drug-Eluting Peripheral Stent in treatment of narrowing of the femoropopliteal arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zilver® PTX® Drug-Eluting Peripheral Stent | Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-11-18
- Completion
- 2021-02-15
- First posted
- 2013-07-17
- Last updated
- 2022-03-02
- Results posted
- 2018-07-03
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01901289. Inclusion in this directory is not an endorsement.